Molecular Analysis of the Ig Repertoire in MS

MS 中 Ig 库的分子分析

基本信息

  • 批准号:
    6580924
  • 负责人:
  • 金额:
    $ 22.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-12-15 至 2005-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Multiple Sclerosis (MS) is an inflammatory, demyelinating disease of the Central Nervous System (CNS) which likely involves an autoimmune mechanism directed against self-myelin associated antigens. There is substantial evidence suggesting that B cells are involved in at least one mechanism of MS pathogenesis. However, both functional and molecular analysis of the immunoglobulins (Ig's) produced by clonally expanded CSF B cells has been limited. We hypothesize that a subset of clonally expanded B cells in the CSF of MS patients is involved in at least one mechanism of MS pathogenesis by producing antibodies that bind to myelin associated antigens. In order to identify complete Ig rearrangements that may play a role in the autoimmune activities evidenced in MS patients and test for their antigenic specificity, we intend to define the Ig repertoires in the CSF of MS patients in order to identify Ig's from clonally expanded B cells. We then plan to determine the antigenic specificity of these unique Ig rearrangements by cloning both the heavy and light chain segments into an expression vector, isolating the resultant Fab fragments, and testing them for their antigenic specificity. We can also use PCR to track the persistence of these clones in the original MS patients. Moreover, we can determine if other MS patients have the same clonally expanded B cells in their CSF. These studies provide the necessary foundation to initiate and assess the potential role of B cells in at least one mechanism of MS pathogenesis, and ultimately will allow us to explore whether generating specific immunotherapies directed against these clonally expanded B cells in the future is warranted.
描述(由申请人提供):多发性硬化症(MS)是一种中枢神经系统(CNS)的炎性脱髓鞘疾病,可能涉及针对自身髓鞘相关抗原的自身免疫机制。有大量证据表明,B细胞参与了至少一种MS发病机制。然而,克隆扩增的CSF B细胞产生的免疫球蛋白(IG)的功能和分子分析都受到限制。我们假设MS患者CSF中克隆扩增的B细胞亚群通过产生与髓鞘相关抗原结合的抗体参与MS发病机制的至少一种。为了鉴定可能在MS患者中证实的自身免疫活性中起作用的完全IG重排并测试其抗原特异性,我们打算定义MS患者CSF中的IG库,以鉴定来自克隆扩增的B细胞的IG。然后,我们计划通过将重链和轻链片段克隆到表达载体中,分离得到的Fab片段,并测试它们的抗原特异性来确定这些独特的IG重排的抗原特异性。我们还可以使用PCR来追踪这些克隆在原始MS患者中的持续性。此外,我们可以确定其他MS患者的CSF中是否具有相同的克隆扩增的B细胞。这些研究为启动和评估B细胞在MS发病机制中的至少一种机制中的潜在作用提供了必要的基础,最终将使我们能够探索将来是否有必要针对这些克隆扩增的B细胞产生特异性免疫疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NANCY L MONSON其他文献

NANCY L MONSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NANCY L MONSON', 18)}}的其他基金

Contribution of plasmablasts in the conversion of transverse myelitis to multiple sclerosis
浆母细胞在横贯性脊髓炎转化为多发性硬化症中的作用
  • 批准号:
    10376290
  • 财政年份:
    2018
  • 资助金额:
    $ 22.23万
  • 项目类别:
Contribution of plasmablasts in the conversion of transverse myelitis to multiple sclerosis
浆母细胞在横贯性脊髓炎转化为多发性硬化症中的作用
  • 批准号:
    10132408
  • 财政年份:
    2018
  • 资助金额:
    $ 22.23万
  • 项目类别:
Immune Profiling of Encephalitis
脑炎的免疫分析
  • 批准号:
    9169078
  • 财政年份:
    2016
  • 资助金额:
    $ 22.23万
  • 项目类别:
Immune Profiling of Encephalitis
脑炎的免疫分析
  • 批准号:
    9305166
  • 财政年份:
    2016
  • 资助金额:
    $ 22.23万
  • 项目类别:
Molecular Analysis of the Ig Repertoire in MS
MS 中 Ig 库的分子分析
  • 批准号:
    6837606
  • 财政年份:
    2002
  • 资助金额:
    $ 22.23万
  • 项目类别:
Molecular Analysis of the Ig Repertoire in MS
MS 中 Ig 库的分子分析
  • 批准号:
    6688937
  • 财政年份:
    2002
  • 资助金额:
    $ 22.23万
  • 项目类别:

相似海外基金

Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
  • 批准号:
    502607
  • 财政年份:
    2024
  • 资助金额:
    $ 22.23万
  • 项目类别:
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
  • 批准号:
    502578
  • 财政年份:
    2024
  • 资助金额:
    $ 22.23万
  • 项目类别:
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
  • 批准号:
    MR/Y008847/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.23万
  • 项目类别:
    Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
  • 批准号:
    BB/Y002180/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.23万
  • 项目类别:
    Research Grant
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
  • 批准号:
    EP/Y024540/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.23万
  • 项目类别:
    Fellowship
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
  • 批准号:
    24K19237
  • 财政年份:
    2024
  • 资助金额:
    $ 22.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
  • 批准号:
    MR/Y003616/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.23万
  • 项目类别:
    Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
  • 批准号:
    MR/Y033698/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.23万
  • 项目类别:
    Research Grant
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
  • 批准号:
    479128
  • 财政年份:
    2023
  • 资助金额:
    $ 22.23万
  • 项目类别:
    Operating Grants
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
  • 批准号:
    23H03716
  • 财政年份:
    2023
  • 资助金额:
    $ 22.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了